Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Non Operating Income (2016 - 2025)

OptimizeRx (OPRX) has disclosed Non Operating Income for 16 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 23.0% to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.7 million through Dec 2025, up 16.43% year-over-year, with the annual reading at -$4.7 million for FY2025, 16.48% up from the prior year.
  • Non Operating Income hit -$1.1 million in Q4 2025 for OptimizeRx, down from -$1.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $721000.0 in Q2 2023 to a low of -$1.5 million in Q1 2024.
  • Historically, Non Operating Income has averaged -$415786.2 across 5 years, with a median of $467.0 in 2021.
  • Biggest five-year swings in Non Operating Income: soared 22166566.67% in 2023 and later crashed 329.47% in 2024.
  • Year by year, Non Operating Income stood at $2382.0 in 2021, then skyrocketed by 22507.56% to $538512.0 in 2022, then tumbled by 255.24% to -$836000.0 in 2023, then tumbled by 70.57% to -$1.4 million in 2024, then increased by 23.0% to -$1.1 million in 2025.
  • Business Quant data shows Non Operating Income for OPRX at -$1.1 million in Q4 2025, -$1.0 million in Q3 2025, and -$1.5 million in Q2 2025.